Just reading Dr Igor Markov's as yet unpublished study "CBIS Report 8. Toxicological Diagnosis".
This is a study in which Dr Markov performed a
toxicological analysis of the blood of 818 patients with CBIS and nephrodysbacteriosis, and found that CBIS patients have high levels of toxic proteins originating from bacteria in their blood.
The analysis of bacterial toxins in the blood was done by means of the
Toxicon diagnostic system, a lab test which was developed by a group of Ukrainian scientists led by pediatric toxicologist Dr Borys S Sheiman.
The Toxicon lab test detects what are called toxic proteomes of bacteria (toxicoproteomics).
According to the Toxicon test, Dr Markov found the majority of CBIS patients (81%) have
severe toxemia, and 17% have moderate toxemia. Toxemia is blood poisoning from bacterial toxins.
In terms of the bacterial species that these bacterial toxins originated from, in 50% of CBIS patients, the toxins came from Enterococcus faecalis.
So Enterococcus faecalis toxins are the ones most commonly found in the blood of CBIS patients. And this matches with Dr Markov's urine tests for kidney dysbiosis infection, which find that Enterococcus is the most common pathogen isolated from the urine in CBIS patients.
Furthermore, the frequency that other bacterial toxins were found in the blood in CBIS roughly corresponds to the frequency these bacteria are found in the kidneys, as the following data indicates:
The table below shows the bacteria whose toxins are found in the blood of CBIS patients, and the percentage of CBIS patients who have these toxins:
Bacterial Toxins Found in the Blood of CBIS Patients:
- Enterococcus faecalis — in 50% of patients
- Escherichia coli — 12%
- Enterococcus faecalis + Escherichia coli (both together) — 27%
- Staphylococcus aureus or Staphylococcus haemolyticus — 6%
- Klebsiella pneumonia — 4%
- Pseudomonas aeruginosa — 1%
The table below shows the bacteria found in the kidneys of CBIS patients, and the percentage of CBIS patients who have these bacteria:
Bacterial Species Found in the Urine of CBIS Patients:
1
- Enterococcus + Escherichia coli (together) in 93% of patients
- Enterococcus — 37%
- Escherichia coli — 25%
- Staphylococcus — 10%
- Klebsiella — 9%
- Streptococcus — 5%
- Enterobacter — 4%
- Morganella — 2%
So this data certainly seem to corroborate Dr Markov's CBIS theory of ME/CFS, as not only does he find bacteria in the kidneys in CBIS patients, but he also finds high levels of toxins from those bacteria in the blood of these patients.
The Toxicon test is not able to identify specific bacteria toxins, but it is able to determine the biological activity of the toxins, and the test found the toxins have cytolytic and autoimmune activity.
The Toxicon lab test found that the detoxification and elimination of toxic proteomes from the blood of CBIS patients was mainly carried out through
macrophages of mesenchymal origin in 75% of patients, through the liver in 23% of patients, and via the kidneys in 2% of patients.
So macrophages are the main route of detoxification. (I would guess that the route of detoxification might perhaps depend on the nature of the bacteria toxins present).
Since the macrophage system seems to be the main route of toxic bacterial proteome detoxification, if we could find some drugs or supplements which would stimulate the macrophage detoxification process, then might reduce levels of bacterial toxins in the blood, which in turn may improve ME/CFS symptoms.
I wonder if the benefits some ME/CFS patients have experienced from the macrophage activating factor
GcMAF might be explained in terms of GcMAF stimulating macrophage detoxification activities? Though I am not sure if there is a connection between GcMAF and the speed of the macrophage detoxification process.